]> 2026-08-09T12:52:58+00:00 Merck 14 en 2007-10-04T10:56:37Z 2454377.9559838 Merck Rofecoxib 0 en Rofecoxib Richard Clark (pharmacologist) 0 en Richard Clark (pharmacologist) Rahway, New Jersey 0 en Rahway, New Jersey Merck Serono 0 en Merck Serono Merck family 0 en Merck family Whitehouse Station, New Jersey 0 en Whitehouse Station, New Jersey Merck Sharp & Dohme 0 en Merck Sharp & Dohme Vytorin 0 en Vytorin Ezetimibe/Simvastatin indications and usage 0 en Ezetimibe/Simvastatin indications and usage Ezetimibe/Simvastatin dosage and administration 0 en Ezetimibe/Simvastatin dosage and administration Ezetimibe/Simvastatin dosage forms and strengths 0 en Ezetimibe/Simvastatin dosage forms and strengths Vytorin contraindications 0 en Vytorin contraindications Ezetimibe/Simvastatin warnings and precautions 0 en Ezetimibe/Simvastatin warnings and precautions Ezetimibe/Simvastatin adverse reactions 0 en Ezetimibe/Simvastatin adverse reactions Vytorin drug interactions 0 en Vytorin drug interactions Ezetimibe/Simvastatin use in specific populations 0 en Ezetimibe/Simvastatin use in specific populations Ezetimibe/Simvastatin overdosage 0 en Ezetimibe/Simvastatin overdosage Ezetimibe/Simvastatin description 0 en Ezetimibe/Simvastatin description Ezetimibe/Simvastatin clinical pharmacology 0 en Ezetimibe/Simvastatin clinical pharmacology Ezetimibe/Simvastatin nonclinical toxicology 0 en Ezetimibe/Simvastatin nonclinical toxicology Ezetimibe/Simvastatin clinical studies 0 en Ezetimibe/Simvastatin clinical studies Ezetimibe/Simvastatin how supplied storage and handling 0 en Ezetimibe/Simvastatin how supplied storage and handling Ezetimibe/Simvastatin labels and packages 0 en Ezetimibe/Simvastatin labels and packages Rofecoxib detailed information 0 en Rofecoxib detailed information Alendronate detailed information 0 en Alendronate detailed information Alendronate detailed information 0 en Alendronate detailed information Ezetimibe/Simvastatin adverse reactions 0 en Ezetimibe/Simvastatin adverse reactions Ezetimibe/Simvastatin clinical pharmacology 0 en Ezetimibe/Simvastatin clinical pharmacology Ezetimibe/Simvastatin clinical studies 0 en Ezetimibe/Simvastatin clinical studies Ezetimibe/Simvastatin description 0 en Ezetimibe/Simvastatin description Ezetimibe/Simvastatin dosage and administration 0 en Ezetimibe/Simvastatin dosage and administration Ezetimibe/Simvastatin dosage forms and strengths 0 en Ezetimibe/Simvastatin dosage forms and strengths Ezetimibe/Simvastatin how supplied storage and handling 0 en Ezetimibe/Simvastatin how supplied storage and handling Ezetimibe/Simvastatin indications and usage 0 en Ezetimibe/Simvastatin indications and usage Ezetimibe/Simvastatin labels and packages 0 en Ezetimibe/Simvastatin labels and packages Ezetimibe/Simvastatin nonclinical toxicology 0 en Ezetimibe/Simvastatin nonclinical toxicology Ezetimibe/Simvastatin overdosage 0 en Ezetimibe/Simvastatin overdosage Ezetimibe/Simvastatin use in specific populations 0 en Ezetimibe/Simvastatin use in specific populations Ezetimibe/Simvastatin warnings and precautions 0 en Ezetimibe/Simvastatin warnings and precautions Merck Serono 0 en Merck Serono Merck Sharp & Dohme 0 en Merck Sharp & Dohme Merck family 0 en Merck family Rahway, New Jersey 0 en Rahway, New Jersey Richard Clark (pharmacologist) 0 en Richard Clark (pharmacologist) Rofecoxib 0 en Rofecoxib Rofecoxib detailed information 0 en Rofecoxib detailed information Vytorin 0 en Vytorin Vytorin contraindications 0 en Vytorin contraindications Vytorin drug interactions 0 en Vytorin drug interactions Whitehouse Station, New Jersey 0 en Whitehouse Station, New Jersey INST 102 en INST